Wikidata

(Q38963454)

English

MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1.

scientific article published on January 2014

In more languages

Statements

title
MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
25150313
retrieved
8 September 2017
publication date
1 January 2014
1 reference
stated in
Europe PubMed Central
PubMed ID
25150313
retrieved
8 September 2017
page(s)
680-689
1 reference
stated in
Europe PubMed Central
PubMed ID
25150313
retrieved
8 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q38963454&oldid=1584551096"